Earnings, deals and disclosures from Japan's listed materials & chemicals companies, in English.
METI has certified Central Glass's plan to build new anhydrous hydrofluoric acid capacity at its Ube plant, unlocking as much as ¥17.6bn in subsidy under Japan's economic-security law, though the company says investment details and the near-term earnings impact remain modest.
The Tokyo-listed colorant and pigment maker will stop offset-ink production in Sapporo by December 2026 and close the site by March 2027, while its Osaka colorant plant runs until September 2028 ahead of a March 2029 closure, as it exits businesses that made up about 5% of last year's group sales to fund a push toward IT, electronics and mobility materials.
Kumiai Chemical now expects full-year sales of ¥175.0bn, up 8% from its December guidance, but has cut operating profit guidance 62.5% to ¥2.7bn after generic rivals crushed prices for one of its export herbicides and forced an inventory writedown, even as equity-method gains and yen-driven forex gains cushioned the ordinary-profit line and the dividend forecast stayed at ¥24 a share.
Sekisui Chemical has agreed to pay about A$335mn for 51% of Brisbane homebuilder Ausbuild, with a later purchase planned to lift its stake to 90%, as it looks to bring its Sekisui Heim factory-built housing method into Ausbuild's townhouse business amid Queensland's chronic housing shortage.
Oasis Management now holds 14.41 percent of Kobayashi Pharmaceutical and has told regulators it may propose dismissing the representative director, changing the board, delisting the company, or clearing the way for an outside buyer to take majority control within 12 months, none of which has been agreed or announced.
Miraial's interim profit rose 52% on AI-linked semiconductor demand for its plastic components, but a debt-funded marine-instrument acquisition added ¥826.7mn of goodwill and a ¥1.9bn covenanted loan, pulling its equity ratio down to 71.3% from 85.7%.
JFE Holdings priced a ¥20bn, five-year bond at 2.703% on September 9, with net proceeds set aside entirely to redeem part of a bond maturing nine days later, not to fund new capital spending.
FUJIFILM is selling its Chinese printing-plate subsidiary and ceding sales rights outside Japan, the US, Canada and Mexico to Huangshan Jinruitai Technology, shrinking a unit that made up less than 1% of group revenue while it weighs a broader spin-off of the segment.
Generative-AI datacenter demand pushed first-half net income at resin maker Miraial up 52% to ¥431mn, even as its April acquisition of a marine-instrument maker piled on ¥1.9bn of new borrowing and forced the company to introduce an adjusted-profit metric to smooth out the deal's goodwill and M&A costs.
Nippon Paper is closing its wholly owned Hungarian subsidiary that makes a lithium-ion battery chemical, booking a roughly ¥5bn impairment as it blames shifting European and US EV subsidies and rules for killing the plant's economics after local production began in 2025.
Tokyo Stock Exchange approval for Crasus Chemical's listing removes the sole condition on Resonac's planned October 1 split, under which shareholders get one new share for every Resonac share held on September 30 and a ¥303.9bn-revenue petrochemicals business comes off Resonac's consolidated books.
A joint EDINET filing shows Nomura Securities, Nomura International and Nomura Asset Management holding just under 50 million JFE Holdings shares between them, with over 13 million tied to bonds carrying share-subscription rights rather than a takeover push.
Nippon Paper Industries lifted its expected non-consolidated gain from a share sale to about ¥82.7bn, up from ¥26.3bn, and added a previously undisclosed ¥36.2bn consolidated gain, in a September 2 correction that also adds a newly disclosed event dated September 1.
A policy stake Kobe Steel has held since 1999 gets its first outside claim: 1.05 million shares go on loan to Nomura for an over-allotment option, with the rest locked up until December 8.
Toyobo is transferring 297,000 square meters of land at its El Salvador unit IUSA, due to close at the end of November 2026, in two tranches through May 2027, booking gains as special items but withholding the sale price by agreement with the buyers.
Osaka Titanium priced its public offering at ¥2,592 a share, raising ¥17.4bn, below the ¥19.2bn estimate it published in August, and scrapped a fallback plan to use leftover cash for debt repayment, committing up to ¥19.9bn to sponge-titanium capacity growth at Amagasaki by March 2028; a same-day filing showing two asset managers lifting their combined stake to 14.61% is an unrelated passive-holding update.
Nifco used an off-auction ToSTNeT-3 trade to buy back 7.54 million shares for ¥39.96bn on September 1, using nearly all the cash and share capacity under a buyback programme its board approved a day earlier.
Nippon Paper priced the sale of a large Lintec stake at ¥63.6bn after Lintec's ¥30bn ToSTNeT-3 buyback trimmed the block, and underwriters routed just over five million shares to European and Asian buyers, with settlement due September 8.
Tri Chemical Laboratories now expects ¥6.57bn in net profit for the year to January 2027, up from a ¥4.6bn forecast in March, after chipmakers' capital spending in China and Taiwan and stronger Korean memory output pushed first-half earnings well past plan.
A March ransomware attack knocked out COTA's servers, forcing months of manual accounting work and pushing the haircare maker's annual filing past its ordinary deadline, and the company now says its internal financial controls were not effective as a result.
Nippon Shokubai now expects to spend about ¥43.0bn, up from ¥37.5bn, on its Kitakyushu LiFSI plant and to start commercial output in December 2028 instead of July 2028, citing delayed land purchase and higher copper, petroleum and construction costs, while the government's ¥12.5bn subsidy commitment holds steady.
Investors priced the chemical maker's two-year notes at 2.048% and its five-year notes at 2.659%, with every yen of the proceeds earmarked to retire commercial paper due by the end of September.
Hodogaya Chemical closed its takeover of Hungarian API maker Framochem on August 25, giving Japan's original phosgene producer a European manufacturing base for the first time, though the earnings effect for the year to March 2027 is still under review.
A fresh EDINET filing shows Oji Holdings sold KPP Group Holdings shares on 35 separate trading days this summer, cutting a legacy cross-shareholding to 13.20% from 14.22% with no stated end point.